DR. MIHAIL OBROCEA, M.D.
Osteopathic Medicine at Avenue Paine, Santa Clarita, CA
License number
California D0063020
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California D0063020
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
28903 Avenue Paine, Santa Clarita, CA 91355
Phone
(661) 775-5365
(661) 775-2080 (Fax)
(661) 775-2080 (Fax)
Organization information
See more information about MIHAIL OBROCEA at bizstanding.comMihail Obrocea MD
28903 Ave Paine, Valencia, CA 91355
Industry:
Internist
Phone:
(661) 775-5365 (Phone)
Mihail Obrocea
Professional information
Dr. Mihail Obrocea - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Certifications:
Internal Medicine, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1500 Seaport Blvd, Redwood City 94063
28903 Avenue Paine, Valencia 91355
1500 Seaport Blvd, Redwood City 94063
28903 Avenue Paine, Valencia 91355
28903 Avenue Paine, Valencia 91355
1500 Seaport Blvd, Redwood City 94063
28903 Avenue Paine, Valencia 91355
Education:
Medical School
Fac Of Med
Yale U Sch Med/Norwalk Hosp
Dartmouth Med Sch
Fac Of Med
Yale U Sch Med/Norwalk Hosp
Dartmouth Med Sch
Cancer Immunotherapy And Method Of Treatment
US Patent:
2011027, Nov 10, 2011
Filed:
Oct 22, 2010
Appl. No.:
12/910778
Inventors:
Adrian Ion Bot - Valencia CA, US
Zhiyong Qiu - San Gabriel CA, US
David C. Diamond - West Hills CA, US
Mihail Obrocea - Santa Clarita CA, US
Zhiyong Qiu - San Gabriel CA, US
David C. Diamond - West Hills CA, US
Mihail Obrocea - Santa Clarita CA, US
Assignee:
MANNKIND CORPORATION - Valencia CA
International Classification:
A61K 39/00, A61P 37/04, A61P 35/00
US Classification:
4242771
Abstract:
The instant disclosure relates to methods for treating a cancer patient with an active immunotherapeutic, wherein the methods include assessing a patient's pre-existing immunoreactivity to at least one target antigen, choosing an immunotherapeutic regimen based on the level of pre-existing immunoreactivity, and administering an active immunotherapeutic according to the regimen.